Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
NCT05481931
·
clinicaltrials.gov ↗
COMPLETED
Status
756
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
prabotulinumtoxinA
Sponsor
Evolus, Inc.
Collaborators
[object Object]